BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 29313812)

  • 1. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development.
    Bowerman M; Murray LM; Scamps F; Schneider BL; Kothary R; Raoul C
    Eur J Med Genet; 2018 Nov; 61(11):685-698. PubMed ID: 29313812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
    Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
    Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
    Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
    BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN.
    Groen EJ; Fumoto K; Blokhuis AM; Engelen-Lee J; Zhou Y; van den Heuvel DM; Koppers M; van Diggelen F; van Heest J; Demmers JA; Kirby J; Shaw PJ; Aronica E; Spliet WG; Veldink JH; van den Berg LH; Pasterkamp RJ
    Hum Mol Genet; 2013 Sep; 22(18):3690-704. PubMed ID: 23681068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice.
    Turner BJ; Alfazema N; Sheean RK; Sleigh JN; Davies KE; Horne MK; Talbot K
    Neurobiol Aging; 2014 Apr; 35(4):906-15. PubMed ID: 24210254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
    Turner BJ; Parkinson NJ; Davies KE; Talbot K
    Neurobiol Dis; 2009 Jun; 34(3):511-7. PubMed ID: 19332122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies.
    Kariya S; Re DB; Jacquier A; Nelson K; Przedborski S; Monani UR
    Hum Mol Genet; 2012 Aug; 21(15):3421-34. PubMed ID: 22581780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and genotypic studies of ALS cases in ALS-SMA families.
    Corcia P; Vourc'h P; Blasco H; Couratier P; Dangoumau A; Bellance R; Desnuelle C; Viader F; Pautot V; Millecamps S; Bakkouche S; Salachas F; Andres CR; Meininger V; Camu W
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):432-437. PubMed ID: 29493298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMN complex member Gemin3 self-interacts and has a functional relationship with ALS-linked proteins TDP-43, FUS and Sod1.
    Cacciottolo R; Ciantar J; Lanfranco M; Borg RM; Vassallo N; Bordonné R; Cauchi RJ
    Sci Rep; 2019 Dec; 9(1):18666. PubMed ID: 31822699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUS-SMN protein interactions link the motor neuron diseases ALS and SMA.
    Yamazaki T; Chen S; Yu Y; Yan B; Haertlein TC; Carrasco MA; Tapia JC; Zhai B; Das R; Lalancette-Hebert M; Sharma A; Chandran S; Sullivan G; Nishimura AL; Shaw CE; Gygi SP; Shneider NA; Maniatis T; Reed R
    Cell Rep; 2012 Oct; 2(4):799-806. PubMed ID: 23022481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology.
    Comley LH; Nijssen J; Frost-Nylen J; Hedlund E
    J Comp Neurol; 2016 May; 524(7):1424-42. PubMed ID: 26502195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways.
    Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ
    Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
    Alrafiah AR
    In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMN1 gene study in three families in which ALS and spinal muscular atrophy co-exist.
    Corcia P; Khoris J; Couratier P; Mayeux-Portas V; Bieth E; De Toffol B; Autret A; Müh JP; Andres C; Camu W
    Neurology; 2002 Nov; 59(9):1464-6. PubMed ID: 12427909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of the SMN genes in the genetics of sporadic ALS.
    Corcia P; Camu W; Praline J; Gordon PH; Vourch P; Andres C
    Amyotroph Lateral Scler; 2009; 10(5-6):436-40. PubMed ID: 19922137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of amyotrophic lateral sclerosis: A review.
    Mathis S; Goizet C; Soulages A; Vallat JM; Masson GL
    J Neurol Sci; 2019 Apr; 399():217-226. PubMed ID: 30870681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spliceosome integrity is defective in the motor neuron diseases ALS and SMA.
    Tsuiji H; Iguchi Y; Furuya A; Kataoka A; Hatsuta H; Atsuta N; Tanaka F; Hashizume Y; Akatsu H; Murayama S; Sobue G; Yamanaka K
    EMBO Mol Med; 2013 Feb; 5(2):221-34. PubMed ID: 23255347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress granules in the spinal muscular atrophy and amyotrophic lateral sclerosis: The correlation and promising therapy.
    Hu L; Mao S; Lin L; Bai G; Liu B; Mao J
    Neurobiol Dis; 2022 Aug; 170():105749. PubMed ID: 35568100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
    O'Connor DM; Boulis NM
    Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.